Left ventricular dysfunction and cardiac arrhythmias are frequent in type 2 myotonic dystrophy: A case control study

Neuromuscular Disorders

Volumn 19, Issue 7, 2009, Pages 468-472

  Wahbi, Karim ^a   Meune, Christophe ^b   Bécane, Henri Marc ^a   Laforêt, Pascal ^a   Bassez, Guillaume ^a   Lazarus, Arnaud ^c   Radvanyi Hoffman, Hélène ^d   Eymard, Bruno ^a   Duboc, Denis ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b InParys Clinical Research Group ^*  (France)

^c InParys Clinical Research Group   (France)

^d HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Arrhythmia; Myotonic dystrophy type 2; Pacemaker; PROMM; Ventricular dysfunction

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOTONIC DYSTROPHY; PREVALENCE; PRIORITY JOURNAL; STROKE; SYSTOLIC DYSFUNCTION;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; CASE-CONTROL STUDIES; COMORBIDITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEART ARREST; HEART VENTRICLES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MYOCARDIUM; MYOTONIC DISORDERS; PREVALENCE; STROKE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67649635616     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.04.012     Document Type: Article

References (14)

1. Brook J.D., McCurrah M.E., Harley H.G., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3 end of a transcript encoding a protein kinase family member. Cell 68 (1992) 799-808
2. Liquori C., Ricker K., Moseley M.L., et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293 (2001) 864-867
3. Taneja K.L., McCurrach M., Schalling M., Housman D., and Singer R.H. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 128 (1995) 995-1002
4. Day J.W., Ricker K., Jacobsen J.F., et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60 (2003) 657-664
5. Mathieu J., Allard P., Potvin L., Prevost C., and Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 52 (1999) 1658-1662
6. de Die-Smulders C.E., Höweler C.J., Thijs C., et al. Age and causes of death in adult-onset myotonic dystrophy. Brain 121 (1998) 1557-1563
7. Meola G., Sansone V., Marinou K., et al. Proximal myotonic myopathy: a syndrome with a favourable prognosis?. J Neurol Sci 193 (2002) 89-96
8. Schoser B.G., Ricker K., Schneider-Gold C., et al. Sudden cardiac death in myotonic dystrophy type 2. Neurology 63 (2004) 2402-2404
9. von zur Mühlen F., Klass C., Kreuzer H., Mall G., Giese A., and Reimers C.D. Cardiac involvement in proximal myotonic myopathy. Heart 79 (1998) 619-621
10. Merlevede K., Vermander D., Theys P., Legius E., Ector H., and Robberecht W. Cardiac involvement and CTG expansion in myotonic dystrophy. J Neurol 249 (2002) 693-698
11. Wahbi K., Meune C., Bassez G., et al. Left ventricular non-compaction in a patient with myotonic dystrophy type 2. Neuromuscul Disord. 18 (2008) 331-333
12. Walton J.N. Disorders of voluntary muscle (1981), Churchill Livingstone, London p. 451-5
13. Bassez G., Chapoy E., Bastuji-Garin S., et al. Type 2 myotonic dystrophy can be predicted by the combination of type 2 muscle fiber central nucleation and scattered atrophy. J Neuropathol Exp Neurol 67 (2008) 319-325
14. Lazarus A., Varin A., Ounnoughene Z., et al. Relationships among electrophysiological findings and clinical status, heart function, and extent of dna mutation in myotonic dystrophy A. Circulation 99 (1999) 1041-1046